<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>623</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15652293</PubmedId>
            <Abstract>In order to evaluate the immunogenicity and protective efficacy of anthrax vaccine candidates a suitable small animal model is required. The inbred A/J strain of mouse has been selected as a potential model, and its immune response to immunisation with recombinant protective antigen (rPA) vaccine characterised, by assessment of rPA specific antibody production, and protection against injected challenge, with the unencapsulated STI strain of Bacillus anthracis. Studies were conducted to determine the time required post immunisation to develop a protective immune response, to define the minimum protective dose of vaccine required and to assess the long-term immune response to immunisation. From the results of these studies it was possible to establish that the A/J mouse is a consistent and robust small animal model for rPA vaccine testing. A comparison of the immune response to rPA vaccine immunisation in the Turner Outbred (TO) mouse strain was also conducted. Both inbred and outbred mouse strains displayed a predominantly Th2 biased immune response and showed a comparable antibody response to rPA immunisation. An assessment of protection in the TO mouse against aerosol challenge with the fully virulent strain of B. anthracis, Ames, was also made.</Abstract>
            <ArticleYear>2005</ArticleYear>
            <ArticlePages>33-40</ArticlePages>
            <ArticleTitle>Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Flick-Smith</LastName>
                    <ForeName>H C</ForeName>
                </Author>
                <Author>
                    <LastName>Waters</LastName>
                    <ForeName>E L</ForeName>
                </Author>
                <Author>
                    <LastName>Walker</LastName>
                    <ForeName>N J</ForeName>
                </Author>
                <Author>
                    <LastName>Miller</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Stagg</LastName>
                    <ForeName>A J</ForeName>
                </Author>
                <Author>
                    <LastName>Green</LastName>
                    <ForeName>M</ForeName>
                </Author>
                <Author>
                    <LastName>Williamson</LastName>
                    <ForeName>E D</ForeName>
                </Author>
            </Authors>
            <Affiliations>Defence Science and Technology Laboratory, Porton Down, Salisbury SP4 0JQ, UK. hcfsmith@dstl.gov.uk &lt;hcfsmith@dstl.gov.uk&gt;</Affiliations>
            <ArticleChemicalList>Anthrax Vaccines;Antibodies, Bacterial;Antigens, Bacterial;Bacterial Toxins;Immunoglobulin G;Vaccines, Synthetic;anthrax toxin</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Anthrax(immunology; prevention &amp; control); Anthrax Vaccines(administration &amp; dosage; immunology); Antibodies, Bacterial(blood); Antigens, Bacterial(immunology); Bacillus anthracis(immunology); Bacterial Toxins(immunology); Disease Models, Animal; Dose-Response Relationship, Immunologic; Immunoglobulin G(blood); Mice; Mice, Inbred A; Survival Analysis; Time Factors; Vaccination; Vaccines, Synthetic(administration &amp; dosage; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>38</Volume>
                <Issue>1</Issue>
                <Title>Microbial pathogenesis</Title>
                <Issn>0882-4010</Issn>
                <MedlineTa>Microb Pathog</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>domain 4 (residues 596-735)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FHYDRNNIAVGADESVVKEAHREVINSSTEGLLLNIDKDIRKILSGYIVEIEDTEGLKEVINDRYDMLNISSLRQDGKTFIDFKKYNDKLPLYISNPNYKVNVYAVTKENTIINPSENGDTSTNGIKKILIFSKKGYEIG</LinearSequence>
                        <StartingPosition>625</StartingPosition>
                        <EndingPosition>764</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA22637.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>260799</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>P. 38</LocationOfData>
                <EpitopeId>16149</EpitopeId>
                <ReferenceStartingPosition>596</ReferenceStartingPosition>
                <ReferenceEndingPosition>735</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The peptide numbering corresponds to the mature protein with the signal peptide cleaved.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>1318393</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000253</OrganismId>
                                <Age>6 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>FHYDRNNIAVGADESVVKEAHREVINSSTEGLLLNIDKDIRKILSGYIVEIEDTEGLKEVINDRYDMLNISSLRQDGKTFIDFKKYNDKLPLYISNPNYKVNVYAVTKENTIINPSENGDTSTNGIKKILIFSKKGYEIG</LinearSequence>
                                            <StartingPosition>625</StartingPosition>
                                            <EndingPosition>764</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA22637.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>260799</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>domain 4 (residues 596-735)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with a single dose of 10 µg, 20 µg , or 40 µg of epitope adsorbed to Alhydrogel. Blood samples were collected at days 7, 14, and 21.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Mice immunized with the epitope produced antibodies to recombinant PA by day 14 and displayed comparable titers to sera from mice immunized with recombinant PA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-rPA</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>recombinant protective antigen (rPA)</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA22637.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>260799</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>1318396</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000253</OrganismId>
                                <Age>6 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>FHYDRNNIAVGADESVVKEAHREVINSSTEGLLLNIDKDIRKILSGYIVEIEDTEGLKEVINDRYDMLNISSLRQDGKTFIDFKKYNDKLPLYISNPNYKVNVYAVTKENTIINPSENGDTSTNGIKKILIFSKKGYEIG</LinearSequence>
                                            <StartingPosition>625</StartingPosition>
                                            <EndingPosition>764</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA22637.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>260799</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>domain 4 (residues 596-735)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with a single dose of 10 µg, 20 µg , or 40 µg of epitope adsorbed to Alhydrogel.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were challenged on day 14 or day 21 post immunization with 10^5 STI spores [equivalent to 100 median lethal doses (MLDs)] by the intraperitoneal route and observed for 14 days.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>125</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>60</ResponseFrequency>
                            <AssayComments>Sixty percent of mice immunized with 40 µg of epitope survived 14 days post challenge with 100 MLD (1 MLD = 10^3  STI spores) on day 14 or day 21 post immunization. More mice survived (up to 60%) when challenged with 100 MLD on day 21 versus day 14 post immunization in groups immunized with 10 µg or 20 µg of epitope. Mice immunized with full length rPA were fully protected against challenge at day 21.</AssayComments>
                        </AssayInformation>
                        <Antigen>
                            <AntigenReferenceName>Bacillus anthracis</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>10000292</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

